GenMark Diagnostics Return on Investment 2010-2018 | GNMK

Current and historical return on investment (ROI) values for GenMark Diagnostics (GNMK) over the last 10 years.
GenMark Diagnostics ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2018-12-31 $-0.05B $0.07B -71.01%
2018-09-30 $-0.05B $0.07B -70.03%
2018-06-30 $-0.06B $0.06B -70.44%
2018-03-31 $-0.06B $0.08B -62.13%
2017-12-31 $-0.06B $0.09B -72.95%
2017-09-30 $-0.06B $0.09B -80.56%
2017-06-30 $-0.06B $0.11B -84.94%
2017-03-31 $-0.05B $0.04B -104.08%
2016-12-31 $-0.05B $0.05B -97.56%
2016-09-30 $-0.05B $0.06B -86.38%
2016-06-30 $-0.05B $0.05B -83.72%
2016-03-31 $-0.04B $0.05B -72.43%
2015-12-31 $-0.04B $0.06B -59.42%
2015-09-30 $-0.04B $0.06B -56.76%
2015-06-30 $-0.04B $0.07B -51.74%
2015-03-31 $-0.04B $0.08B -47.48%
2014-12-31 $-0.04B $0.08B -43.58%
2014-09-30 $-0.04B $0.09B -41.13%
2014-06-30 $-0.04B $0.09B -39.81%
2014-03-31 $-0.04B $0.10B -41.49%
2013-12-31 $-0.03B $0.11B -41.46%
2013-09-30 $-0.03B $0.12B -42.03%
2013-06-30 $-0.02B $0.05B -42.20%
2013-03-31 $-0.02B $0.05B -35.44%
2012-12-31 $-0.02B $0.06B -42.11%
2012-09-30 $-0.02B $0.06B -48.09%
2012-06-30 $-0.02B $0.07B -55.00%
2012-03-31 $-0.02B $0.03B -64.23%
2011-12-31 $-0.02B $0.03B -75.00%
2011-09-30 $-0.03B $0.04B -98.31%
2011-06-30 $-0.03B $0.04B -106.67%
2011-03-31 $-0.03B $0.02B -118.68%
2010-12-31 $-0.02B $0.02B -108.11%
2010-09-30 $-0.01B $0.02B -75.47%
2010-06-30 $-0.01B $0.03B -68.97%
2010-03-31 $0.00B $0.00B nan%
2009-12-31 $0.00B $0.00B nan%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.412B $0.071B
GenMark Diagnostics, Inc. is a molecular diagnostics company focused on developing and commercializing its proprietary eSensor(R) detection technology. The eSensor? XT-8 system is the second generation in GenMark Dx's eSensor? platform, utilizing electrochemical detection technology to detect nucleic acids on a microarray. The XT-8 System enables multiplex detection of DNA and RNA targets. The Company has developed four diagnostic tests for use with its XT-8 System. Its Cystic Fibrosis Genotyping Test, which detects pre-conception risks of cystic fibrosis, and its Warfarin Sensitivity Test, which determines an individual's ability to metabolize the oral anticoagulant warfarin, have received FDA clearance. It has also developed a Respiratory Viral Panel Test, which detects the presence of major respiratory viruses, and a Thrombosis Risk Test, which detects an individual's increased risk of blood clots. GenMark Diagnostics, Inc. is based in Pasadena, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $105.261B 23.72
Intuitive Surgical (ISRG) United States $64.748B 60.48
Edwards Lifesciences (EW) United States $39.266B 40.21
Fresenius Medical Care AG KGaA (FMS) Germany $23.664B 16.20
IDEXX Laboratories (IDXX) United States $18.872B 51.39
ABIOMED (ABMD) United States $14.572B 96.19
Teleflex (TFX) United States $13.884B 30.44
Hologic (HOLX) United States $13.648B 20.64
Varian Medical Systems (VAR) United States $12.581B 31.43
DexCom (DXCM) United States $11.613B 444.93
STERIS (STE) United Kingdom $10.406B 26.74
Masimo (MASI) United States $7.109B 44.26
Penumbra (PEN) United States $5.474B 309.73
Integra LifeSciences Holdings (IART) United States $4.712B 22.85
Globus Medical (GMED) United States $4.682B 28.42
LivaNova (LIVN) United Kingdom $4.628B 28.53
Wright Medical Group (WMGI) Netherlands $3.980B 0.00
Tandem Diabetes Care (TNDM) United States $3.969B 0.00
Glaukos (GKOS) United States $2.896B 0.00
Cantel Medical (CMD) United States $2.757B 27.42
Integer Holdings (ITGR) United States $2.736B 22.32
Inogen (INGN) United States $1.966B 39.18
AVANOS MEDICAL, INC (AVNS) United States $1.941B 21.08
Nevro (NVRO) United States $1.885B 0.00
OPKO Health (OPK) United States $1.557B 0.00
Pacific Biosciences Of California (PACB) United States $1.102B 0.00
Accelerate Diagnostics (AXDX) United States $1.083B 0.00
Luminex (LMNX) United States $1.067B 48.74
ORTHOFIX MEDICAL INC (OFIX) United States $1.059B 28.78
Tactile Systems Technology (TCMD) United States $1.045B 198.46
CryoLife (CRY) United States $1.043B 112.44
Veracyte (VCYT) United States $1.006B 0.00
Intersect ENT (XENT) United States $0.968B 0.00
Fluidigm (FLDM) United States $0.938B 0.00
Mesa Laboratories (MLAB) United States $0.875B 35.79
Natus Medical (BABY) United States $0.851B 17.75
AngioDynamics (ANGO) United States $0.811B 26.30
ViewRay (VRAY) United States $0.808B 0.00
AxoGen (AXGN) United States $0.795B 0.00
OrthoPediatrics (KIDS) United States $0.654B 0.00
Quotient (QTNT) Switzerland $0.556B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.462B 48.72
Si-Bone (SIBN) United States $0.440B 0.00
Accuray (ARAY) United States $0.414B 0.00
Pulse Biosciences (PLSE) United States $0.372B 0.00
RTI Surgical (RTIX) United States $0.357B 52.09
IRadimed (IRMD) United States $0.304B 64.19
SeaSpine Holdings (SPNE) United States $0.282B 0.00
Sientra (SIEN) United States $0.276B 0.00
Neuronetics (STIM) United States $0.262B 0.00
Nuvectra (NVTR) United States $0.206B 0.00
ConforMIS (CFMS) United States $0.162B 0.00
Helius Medical Technologies (HSDT) United States $0.159B 0.00
Ekso Bionics Holdings (EKSO) United States $0.153B 0.00
T2 Biosystems (TTOO) United States $0.129B 0.00
Biosig Technologies (BSGM) United States $0.121B 0.00
Sensus Healthcare (SRTS) United States $0.121B 0.00
SOLITON INC (SOLY) $0.114B 0.00
Alphatec Holdings (ATEC) United States $0.114B 0.00
Second Sight Medical Products (EYES) United States $0.106B 0.00
Vermillion (VRML) United States $0.103B 0.00
Apollo Endosurgery (APEN) United States $0.088B 0.00
EDAP TMS (EDAP) France $0.085B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.073B 0.00
Titan Medical (TMDI) Canada $0.065B 0.00
Ra Medical Systems (RMED) United States $0.050B 0.00
Viveve Medical (VIVE) United States $0.044B 0.00
Avinger (AVGR) United States $0.037B 0.00
OBALON THERPTCS (OBLN) United States $0.037B 0.00
Microbot Medical (MBOT) United States $0.034B 0.00
PAVmed (PAVM) United States $0.028B 0.00
DarioHealth (DRIO) Israel $0.027B 0.00
Restoration Robotics (HAIR) United States $0.027B 0.00
Lianluo Smart (LLIT) China $0.026B 0.00
ENDRA Life Sciences (NDRA) United States $0.021B 0.00
Atossa Genetics (ATOS) United States $0.021B 0.00
Bioanalytical Systems (BASI) United States $0.021B 66.67
Dynatronics (DYNT) United States $0.017B 0.00
ReWalk Robotics (RWLK) Israel $0.016B 0.00
Nanovibronix (NAOV) United States $0.015B 0.00
Presbia (LENS) Ireland $0.012B 0.00
Neovasc (NVCN) Canada $0.012B 0.00
Allied Healthcare Products (AHPI) United States $0.007B 0.00
Cesca Therapeutics (KOOL) United States $0.007B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Sunshine Heart Inc (CHFS) United States $0.002B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00